Form 8-K - Current report:
SEC Accession No. 0001193125-17-015969
Filing Date
2017-01-24
Accepted
2017-01-24 09:18:55
Documents
4
Period of Report
2017-01-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d332511d8k.htm 8-K 24611
2 EX-1.1 d332511dex11.htm EX-1.1 216734
3 EX-5.1 d332511dex51.htm EX-5.1 4125
4 EX-10.1 d332511dex101.htm EX-10.1 9729
  Complete submission text file 0001193125-17-015969.txt   256658
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 6503662626
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33221 | Film No.: 17542634
SIC: 2834 Pharmaceutical Preparations